New Results for Targeted Radioligand Therapy 177Lu-NeoB Suggest Promise in Certain Breast and Prostate Cancers 4 months ago ByJohnIn BreakthroughsClinical Trials
European Union Issues New Horizon Europe Health Calls, Funding Phage Therapy and AI-for-Pandemic Preparedness 4 months ago ByJohnIn Breaking News
I-SPY2.2 Trial Adopts Smart Adaptive Design to Personalize Breast Cancer Treatment Regimens 4 months ago ByJohnIn Research Updates
FDA Panel Raises Concerns Over Applicability of STARGLO Trial in DLBCL Despite Positive Outcomes 5 months ago ByJohnIn FDA ApprovalsTop Stories
FDA Grants Full Approval to Novavax’s Nuvaxovid Vaccine with Specific Age and Risk-Conditions Restrictions 5 months ago ByJohnIn FDA ApprovalsFeatured Analysis
New Data Suggests Aficamten Improves Symptoms in Obstructive Hypertrophic Cardiomyopathy Across Diverse Patient Groups 5 months ago ByJohnIn Biopharma HighlightsBreaking NewsClinical TrialsResearch Updates
Novel Bayesian Hybrid Design Could Speed Up Multinational Trials While Preserving Rigor 5 months ago ByJohnIn InnovationPharma Industry Updates
New Hope for Rett Syndrome: TSHA-102 Pivotal Trial Moves into Site Activation Stage 5 months ago ByJohnIn Clinical TrialsInnovationStartups
Bharat Biotech’s Hillchol Oral Cholera Vaccine Clears Phase III with Strong Protection 5 months ago ByJohnIn Clinical TrialsResearch UpdatesVenture Capital
AbCellera Gets Green Light in Canada for First-in-Human Trial of ABCL635 to Treat Menopause Vasomotor Symptoms 5 months ago ByJohnIn Clinical Trials
EMA Greenlights Moleculin’s Phase IIb/III Trial of Annamycin Plus Ara-C in AML 5 months ago ByJohnIn Breaking News
FDA Grants Approval to Emrelis (Telisotuzumab Vedotin) for Advanced NSCLC with c-Met Overexpression 5 months ago ByJohnIn FDA ApprovalsResearch Updates
New Data from Votoplam (PTC518) Offers Hope for Huntingtin Reduction in Huntington’s Disease 5 months ago ByJohnIn Clinical Trials
Merus’ Petosemtamab Plus Keytruda Shows Strong Responses in Head and Neck Cancer Phase II Trial 5 months ago ByJohnIn Biopharma HighlightsResearch UpdatesTop Stories
FDA Approves First Targeted Therapy for KRAS-Mutated Low-Grade Serous Ovarian Cancer 5 months ago ByJohnIn Breaking NewsClinical TrialsFDA Approvals
